Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

H-DL-Thr-OH

    • Product Name H-DL-Thr-OH
    • Alias Threonine
    • Einecs 217-990-3
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    246285

    product_name H-DL-Thr-OH
    chemical_name DL-Threonine
    molecular_formula C4H9NO3
    molecular_weight 119.12 g/mol
    CAS_number 617-20-1
    purity Typically ≥98%
    appearance White crystalline powder
    solubility Soluble in water
    melting_point 256-258°C (dec.)
    optical_activity Racemic mixture (DL form)
    storage_temperature 2-8°C
    pH_range Neutral in solution
    synonyms DL-2-Amino-3-hydroxybutyric acid
    functional_group Amino acid
    IUPAC_name 2-Amino-3-hydroxybutanoic acid

    As an accredited H-DL-Thr-OH factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The chemical H-DL-Thr-OH is packaged in a sealed amber glass bottle containing 25 grams, labeled with product details and safety information.
    Shipping H-DL-Thr-OH is shipped in secure, sealed containers under ambient or refrigerated conditions to preserve its purity and stability. Packaging complies with chemical safety regulations, including clear labeling and documentation. Transport is handled by certified carriers, ensuring prompt delivery while minimizing risk of contamination, degradation, or exposure during transit.
    Storage H-DL-Thr-OH (DL-Threonine) should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area, away from direct sunlight and moisture. Ideally, it should be kept at room temperature (15–25°C). Avoid exposure to strong oxidizing agents or acids. Ensure proper labeling and keep out of reach of incompatible substances to maintain stability and safety.
    Application of H-DL-Thr-OH

    Applications of H-DL-Thr-OH in Industrial Manufacturing

    As a manufacturer specializing in high-purity H-DL-Threonine (H-DL-Thr-OH), we support a range of advanced industries through precisely controlled formulation quality and consistent supply. Each industrial segment below demonstrates specific downstream processing, compliance mandates, and best-practice incorporation of this amino acid intermediate.

    1. Pharmaceutical Peptide Synthesis

    Downstream peptide API manufacturers frequently adopt H-DL-Thr-OH as a protected amino acid building block during solid-phase or liquid-phase peptide synthesis processes. Quality assurance and traceability rank critical in the selection of this intermediate, with regulatory compliance dominating supplier qualification. Its purity, optical definition, and controlled moisture content must meet the requirements for injectable APIs, oral peptides, or diagnostic reagents. Sourcing teams require supplier technical dossiers for batch consistency and impurity data, particularly for projects aiming to meet EMA, US FDA, or NMPA submissions.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients (APIs)
    • USP, EP, JP reference monographs for amino acid starting materials
    • Pharmacopoeia General Chapters relevant to Peptides and Polypeptides
    • ISO 9001:2015-certified Quality Management Systems

    Typical usage ratio

    • 1.03–1.10 mol equivalent per threonine residue in protected chain assembly, adjusted for yield optimization and protection strategy

    Downstream process integration

    • Direct coupling to resin in Fmoc or Boc-based SPPS cycles, following pre-activation by carbodiimide or uronium reagents
    • Solution phase peptide intermediate assembly (acylation steps)
    • Integration during fragment condensation for long-chain therapeutic peptides

    Final product types

    • Therapeutic peptide APIs (e.g., GLP-1 analogues, insulin analogs)
    • Peptide-based diagnostic kits
    • Peptide intermediates for further bioconjugation

    2. Parenteral Nutrition Formulations

    In commercial compounding of amino acid solutions for intravenous (IV) clinical nutrition, H-DL-Thr-OH serves as a controlled threonine supply source. Large-scale formulators must precisely balance amino acid profiles to match human metabolic needs, meeting international pharmacopeial guidelines on ingredient purity and pyrogen limits. The manufacturing process incorporates extensive filtration and heat sterilization, necessitating high-stability raw materials with validated impurity control to prevent degradation under medical storage and use conditions.

    Industry compliance standards

    • USP <797> and <823> for sterile compounding
    • Pharmacopoeia standards for Aqueous Amino Acid Solutions (USP, Ph. Eur., JP)
    • GMP compliance for parenteral nutrition production
    • Endotoxin and bioburden control as per FDA 21 CFR Part 210/211

    Typical usage ratio

    • 0.2–0.45% w/v threonine in finished amino acid IV solutions; precise amount set through nutritional protocol for adults or pediatric use

    Downstream process integration

    • Dissolution into WFI (water for injection) under controlled pH and temperature
    • Co-formulation with other essential and non-essential amino acids, followed by membrane filtration
    • Terminal sterilization and aseptic filling into glass or polymer IV bags

    Final product types

    • Total parenteral nutrition (TPN) solutions
    • Peripheral amino acid injectables
    • Specialized pediatric or neonatal amino acid mixtures

    3. Biotechnological Fermentation Media

    H-DL-Thr-OH functions as a precisely dosed additive to cell culture or fermentation media, supporting the biosynthesis of recombinant proteins, monoclonal antibodies, or vaccine antigens in biotechnological plants. Manufacturers customize media compositions for CHO, E. coli, or yeast systems based on strain requirements and patent constraints. To ensure batch reproducibility, suppliers provide traceable certificates of analysis with specification control of trace metals and endotoxin load. Technicians closely monitor amino acid consumption profiles during each fermentation cycle to prevent metabolic imbalances and optimize yield.

    Industry compliance standards

    • ISO/TS 20399-1:2018 for cell culture media
    • FDA 21 CFR 600–680 applicable to biologics production
    • ICH Q5A/B for biotechnology-derived pharmaceuticals
    • GMP Annex 2 (EU guidelines for biological medicinal products)

    Typical usage ratio

    • 0.05–0.20 g/L in basal or feed media, with adjustments informed by species- and process-specific amino acid profiling

    Downstream process integration

    • Dosed during initial media formulation (before fermentation inoculation) or added in feed strategy during high-density cell culture
    • Blended with other L- and DL-amino acids, vitamins, and buffer salts
    • Sterile filtration prior to use to protect sensitive fermentations from bioburden

    Final product types

    • Recombinant protein active pharmaceutical ingredients (APIs)
    • Cell culture media for bioprocessing kits
    • Industrial fermentation harvests for enzymes or therapeutic proteins

    4. Medical Device and Diagnostic Reagent Manufacturing

    Within the field of in vitro diagnostics and specialized medical device reagents, precise grades of H-DL-Thr-OH support the formulation of enzyme substrates and calibration solutions. Manufacturers of clinical chemistry kits or biosensor components require amino acid building blocks free of interfering impurities that could compromise analytical baseline or shelf stability. The downstream process incorporates rigorous incoming QC and carefully controlled buffer preparation environments, meeting ISO system requirements and in many cases, IVDR regulations in the EU.

    Industry compliance standards

    • ISO 13485:2016 (quality management for medical devices)
    • EU Regulation 2017/746 on in vitro diagnostic medical devices (IVDR)
    • FDA QSR 21 CFR 820 (Quality System Regulation)
    • CLSI guidelines for quality of clinical laboratory reagents

    Typical usage ratio

    • 10–50 mmol/L in diagnostic buffer preparations; final concentration varies by test system sensitivity and calibration design

    Downstream process integration

    • Weighing and dissolution into diagnostic buffer bases during automated or manual batch manufacturing
    • Blending with stabilizers or enzyme cofactors for storage under controlled temperature and humidity
    • Filtration and container closure prior to end-use packaging

    Final product types

    • Enzyme substrate buffers for clinical analyzers
    • Calibration fluids for biosensor systems
    • Reagent components in point-of-care diagnostic kits

    5. Food-Grade Amino Acid Ingredient Manufacturing

    Food ingredient producers utilize H-DL-Thr-OH as a precursor in the manufacture of amino acid complexes or as a nutritional additive for specialized food applications. Industrial blending in this segment targets sports nutrition powder formulations and amino acid-enriched supplements, with batch standardization verified against global food additive directives. Downstream, production lines operate under HACCP and FSSC 22000 certifications, and end-use quality control screens for allergen contamination or non-permitted additives prior to packing and export distribution.

    Industry compliance standards

    • FAO/WHO Food Additive Specifications (JECFA)
    • GB 2760 (China National Food Safety Standard for food additives)
    • FSSC 22000 (Food Safety Management System Certification)
    • FDA 21 CFR 172.320 (Amino acids permitted in food)

    Typical usage ratio

    • 0.1–2.0% w/w in powdered blends; precise concentration adjusted for local regulatory caps and intended product claims

    Downstream process integration

    • Dry blending with carriers and bulking agents in ribbon or paddle mixers
    • Wet granulation for ready-to-mix beverage base powders
    • In-line metal detection and particle size control prior to final packaging

    Final product types

    • Amino acid sports nutrition supplements
    • Fortified functional food premixes
    • Medical foods and dietary support formulations
    Free Quote

    Competitive H-DL-Thr-OH prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    H-DL-Thr-OH: Experience Meets Precision in Threonine Chemistry

    Crafting Consistency with H-DL-Thr-OH

    Years spent in synthesis sitting amid the hum of glass reactors and the scent of solvents have taught us a few non-negotiables: a batch counts for nothing if consistency is off and trace contaminants overshadow the main act. With H-DL-Thr-OH, or DL-Threonine (CAS 302-84-1), we bring that hard-earned focus to the forefront. This compound, methodically prepared to a purity above 99%, opens reliable doors for research and manufacturing teams who prefer predictable behavior—or, more bluntly, less drama on the line.

    H-DL-Thr-OH hits the right mark for both scale-up and lab work. The needle never swings far on key indices. Optical rotation checks come back clear at “none,” a hallmark of a truly racemic mixture. Any leftover moisture, often the bane of peptide synthesis, stays under the tight threshold of 0.5%. Our filters can pick up the faintest surge in L- or D- contents, so anyone chasing strict chiral control or isotopic labeling doesn’t have to guess.

    Not All Threonine Is Built for Tough Environments

    We have fielded more than our share of calls about the critical dependence of downstream yields on amino acid foundation. In our experience, a faulty starter leads to a string of troubleshooting and, too often, lost investments down the drain—a particularly bitter event in long-chain peptide manufacture or custom API assembly. With H-DL-Thr-OH, the most frequent feedback points to ease of protection and coupling. Experienced chemists who run Fmoc- or Boc-strategy syntheses have pushed our material through cycles involving strong base and repeated deprotections; feedback circles back to the same point: “less racemization, cleaner spots on TLC.”

    As for the technical shape—white crystalline powder with solid flow properties and high solubility in water at room temperature—it blends seamlessly into manual and automated systems. It never gums up glassware with annoying, tenacious residues. Storage headaches fade as our batches consistently pass six-month and twelve-month stability pulls, even under conditions that can make other amino acids sweat. No visible caking, no notorious off-odors, and HPLC checks repeat with the same peak purity.

    Precision in Performance vs. Commodity Options

    Everyone has tried sourcing threonine from the mass-market bin. The catch with those generic products emerges under stress: extra spots in NMR, unwanted baseline drifts in mass spec, or isolated moisture pockets that render a batch useless for solid-phase synthesis. Instead of brushing off these warning signs, we’ve built our operation around removing them at the source. We made the call to bring in higher-purity source streams, install extra in-process controls, and vet purification steps batch-by-batch rather than relying on bulk “statistical” measures.

    Some buyers ask if there’s a meaningful difference between H-DL-Thr-OH and mass-market DL-threonine when running a reaction at room temperature, neutral pH, and quick turnaround. We point to feedback from customers who’ve tried both side-by-side: a batch with higher residual solvent content or trace iron can throw off crystalline structure in peptides, force more clean-up steps, and in the end hit downstream conversion rates. The numbers add up fast when scale increases or purity requirements get stricter, especially for regulated or pharmaceutical work.

    By holding back product that doesn’t meet our standards—even when visually indistinguishable—we keep those downstream complications off the radar. If that means sacrificing yield or batch throughput, that’s the price for batches that work consistently under both standard and more aggressive conditions. This has built loyalty among researchers and formulation teams who need reliability as much as a competitive price.

    Where H-DL-Thr-OH Meets Real-World Demands

    We see H-DL-Thr-OH at work across a variety of settings, with distinctions demanded by end-users who look past surface-level commodity offerings. In pharmaceutical settings, this racemate is often chosen to test for both enantiomeric forms, or as a comparative standard to pure L-Threonine. The even split between D- and L- forms comes into play whenever teams require non-biased conditions to monitor stereospecific reactions or metabolic stability.

    Industrial labs have used our DL-Threonine in pilot runs for bio-based surfactants and specialty catalysts. Large-scale buyers report that uniform powder density reduces batch-to-batch weigh discrepancies, while those building up to scaled fermentation batches find less risk of “hot” spots and better control over process parameters. When moving to spray-drying, there’s a noticeable reduction in clumping and dust, making things easier on operators down the line.

    Life science research is rarely forgiving about supplier slip-ups. H-DL-Thr-OH, specified with narrow impurity thresholds for heavy metals and residual solvents, avoids “mystery peaks” in LCMS or the long troubleshoot cycles that follow. Labs reporting high turnover in protein tagging or peptide mapping cite an absence of buffer interference and no unexpected cross-reactivity compared to some off-the-shelf options. That feedback loop—direct from users—pushes us to continuously refine our purification steps.

    Specifications and How They Shape Outcomes

    Product codes like H-DL-Thr-OH may not mean much to outsiders, but behind every code stands years of calibration, method validation, and production tweaks. Our finished batches meet a typical specification of ≥99% purity by HPLC, measured in-house on validated rigs. Moisture content is kept under 0.5% by direct Karl Fischer titration. Inorganics—especially iron, copper, and calcium—are checked batchwise using ICP-MS. TLC and NMR profiles are checked side by side with primary standards. We handle all testing in our own lab, with results available for every batch shipped.

    Granule size distribution is standardized through dried sieving. Batches that fail these tests are scrapped, not blended or repurposed. Color and odor checks are not afterthoughts: operators trained to spot minor off-white tints or the faintest “burnt” scent have prevented problematic batches from leaving our doors.

    DL-Threonine vs. L-Threonine: Choosing the Right Fit

    Customers familiar with biochemistry already know why DL-Threonine attracts a different crowd than the single-isomer L-threonine. Cell cultures, nutritional supplements, and bioprocessing usually require the L-form, found naturally in living systems. Marketed under its optical isomer specification, L-threonine moves by the ton for animal feed, IV solutions, and specialty human food supplements. DL-Threonine, in contrast, serves broader experimental needs—synthetic chemistry, comparative drug studies, or chiral switch research.

    Some may wonder if the DL-form adds cost or complexity. On the ground, our H-DL-Thr-OH sidesteps those questions. Most reactions targeting either D- or L-form separation use this compound at the front end, both as a cost-saving move and to give researchers freedom to optimize at the bench. In pharmaceutical development, where every enantiomer’s fate matters, access to well-characterized racemates steers method development and regulatory filings.

    From Idea to Batch: Manufacturing Insights

    Making H-DL-Thr-OH means controlling each detail, from precursor integrity to finished lot packaging. We source starting glycolaldehyde and ammonia only from vetted partners who can deliver supply chain traceability down to the farm or mine. Our reactors operate under stringent temperature pairings, guided by operators who spend as much time in the plant as at a desk. By adjusting pH and crystallization schedules, we tune chiral yield without wasting raw material or building up excess inorganic solids.

    We chose water-mediated crystallization for environmental and technical reasons. Other suppliers have stuck with alcohol precipitation, which sometimes brings in more contaminants and solvent residues that don’t scrub out easily. Our team recognized the extra cleaning steps were worth it for the customer-facing batch reliability. Small choices like these accumulate into trustworthy supply over years—not just passing lots through minimum specs.

    Drying and final blending can make or break batch flowability and downstream consistency. Batches destined for pharmaceutical applications run through additional micron filters and undergo extended drying to ensure not even trace amounts of acetone or methanol show up on random checks. We package under nitrogen for long-haul shipments, sidestepping risk from humidity spikes that can sneak through cardboard and plastic during multi-week cross-continent routes.

    Supply Reliability in Turbulent Times

    In the past few years, the global supply environment hasn’t done anyone favors. Ingredients common ten years ago can disappear overnight, or soar in price due to logistics snarls no synthetic chemist wishes to understand. H-DL-Thr-OH stands as a product of strategy as much as chemistry. We locked in multiple raw material sources early, never relying on just one vendor route to keep our lines running.

    Multi-tiered internal inventory means that even when a month throws unpredictable events—natural disasters, factory slowdowns, or regulatory changes—end users don’t face a late arrival or “out of stock” message. Customers in North America and Europe have commented on this repeatedly, noting that their own project timelines ride on the fact that orders show up on time, in expected quality, again and again.

    Shipping such a moisture-sensitive product taught us to never skimp on packaging or tracked delivery. Every batch receives its own set of test results and tracking so that users know exactly what inputs they’re working with, days before a pipette or scoop goes into the jar.

    Continuous Improvement and Customer Feedback

    Most of our best process ideas have come directly from user feedback—both grateful and critical. Some years back, input from a peptide shop flagged a minor but stubborn trace of sulfur on combustion analysis. We traced it back to a cleaning agent at a raw material supplier, adjusted pre-wash steps, and the problem vanished. On another occasion, academic researchers noted inconsistent flowability that interfered with automated loading. We took the batch in question offline, re-blended and re-sieved, then adopted improved mesh-sizing for all runs.

    These stories remind us that process “perfection” rarely sits still. We engage with users regularly: phone calls, emails, and even site visits. The trust built by this openness is, in our view, what keeps clients returning and referring.

    Future Challenges and Solutions in Amino Acid Manufacturing

    Amino acid manufacturing faces relentless new tests: ever-tightening purity demands, regulatory shifts, sustainability targets, and the constant push to do more with less. H-DL-Thr-OH stands as an example of manufacturing responding to—not resisting—these pressures. Every year, we review our solvent recovery, wastewater management, and process energy use in the hunt for smarter, less resource-intensive solutions. New chromatography and membrane technologies entering our plant promise tighter impurity control while minimizing raw material loss.

    We recognize a growing focus from customers on both origin traceability and risk management in their supply chains. Clear batch records, origin certifications, and digital traceability are in the pipeline—less in response to government mandate than to customer expectation. We view this as an opportunity to create a more resilient value chain and differentiate from manufacturers relying solely on cost-cutting measures.

    Our goal remains unchanged: offer a material that performs so reliably that end-users can leave their contingency plans on the shelf. H-DL-Thr-OH is not just a line item in a catalog, but a collaboration between synthesis experts and the scientists who rely on amino acid input to turn a hypothesis into published data, a benchtop reaction into a marketable product, or a trial run into a registered medicine.

    H-DL-Thr-OH: From Our Team to Your Bench

    Ask anyone working at scale—such as those running multi-hundred liter reactors or preparing columns for large-scale purification—what they need from their chemical supplier and you’ll hear familiar words: reliability, transparency, and real-time support. We craft H-DL-Thr-OH not by chasing minimum specs, but by investing in the same level of reliability that we ourselves, as chemists, demand when a failed run costs not just money but the chance to move a project forward on schedule.

    We’ve learned over decades that delivering quality takes more than a printed certificate or a glossy brochure. It’s built in the small steps—the third round of impurity checks, the call-back to a user when a batch doesn’t fit their method, the willingness to hold back a shipment that might “just about” pass standard tests, but falls short of expectations in the field.

    H-DL-Thr-OH reflects those values: straight answers about what users can expect, and an open line to the real-world people making each batch by hand, not algorithms. Whether headed for basic R&D or an intricate commercial process, this threonine is the product of a team that lives and breathes chemistry day in and day out, bringing finished material to market with an eye for detail, accountability, and real partnership.